Itajaí, Brazil Citywide Prevention Program using Ivermectin Significantly Reduced COVID-19 Infection, Hospitalization, and Mortality Rate
A citywide prevention program using ivermectin as prophylaxis for COVID-19 was implemented in Itajaí, a southern city in Brazil in the state of Santa Catarina between July 2020 and December 2020.
In early July, the city mayor of Itajaí, Dr. Volnei José Morastoni announced a citywide use of Ivermectin against COVID-19. The mayor distributed Ivermectin kits totaling 1.5 million tablets to the residents of Itajaí. The study of this program was published on NIH website.
According to this comprehensive study, the regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and death rates. The ivermectin non-users were two times more likely to die of COVID-19 than ivermectin users in the overall population analysis.
